MDGL peer analysis
Madrigal Pharma (MDGL) against its competitors: price, today's move, 1-year return and market value side by side.
MDGL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALT Altimmune | $2.04 | -4.67% | -49.88% | $396.82M |
| IVA Inventiva | $3.65 | -2.14% | -12.05% | – |
| MAZE Maze Therapeutics | $30.48 | -3.18% | -8.25% | – |
| NAMS NewAmsterdam Pharma | $19.56 | -2.49% | -49.48% | – |
| SGMT Sagimet Biosciences | $9.68 | -2.47% | 18.86% | – |
| VKTX Viking Therapeutics | $26.92 | -1.32% | -29.47% | $3.48B |
| MDGL Madrigal Pharma | $430.59 | 0.05% | 0.72% | $9.94B |
- MDGL's peers: ALT (Altimmune), IVA (Inventiva), MAZE (Maze Therapeutics), NAMS (NewAmsterdam Pharma), SGMT (Sagimet Biosciences), VKTX (Viking Therapeutics).
Updated 2026-11-03 00:02 UTC